X0306 4 2016-02-03 true 0001432732 TriVascular Technologies, Inc. TRIV 0001380079 Kramer Michael R C/O TRIVASCULAR TECHNOLOGIES, INC. 3910 BRICKWAY BLVD. SANTA ROSA CA 95403 false true false false Chief Financial Officer Common Stock 2016-02-03 4 M false 15000.00 A 107309.00 D Common Stock 2016-02-03 4 F false 6561.00 5.62 D 100748.00 D Common Stock 2016-02-03 4 D false 8439.00 D 92309.00 D Common Stock 2016-02-03 4 M false 16032.00 2.43 A 108341.00 D Common Stock 2016-02-03 4 F false 7238.00 5.62 D 101103.00 D Common Stock 2016-02-03 4 D false 8794.00 D 92309.00 D Common Stock 2016-02-03 4 D false 92309.00 D 0.00 D Restricted Stock Units (RSU) 2016-02-03 4 M false 15000.00 0.00 D Common Stock 15000.00 0.00 D Stock Options (Right to buy) 2.43 2016-02-03 4 M false 16032.00 0.00 D 2020-10-05 Common Stock 16032.00 0.00 D Each RSU represents a contingent right to receive one share of TRIV common stock. This quantity includes 2,795 ESPP shares. These shares were withheld by the issuer to satisfy tax withholding obligations and calculated for the purposes of the deemed settlement of the RSUs, contingent upon the closing of the Merger (as defined below), utilizing the closing price of the issuers common stock on January 28, 2016. These shares were disposed of pursuant to the merger agreement between the issuer and Endologix, Inc. (such transaction, the Merger). In connection with the closing of the Merger, the reporting person received 0.6312 share of Endologix common stock and $0.34 in cash for each share of issuer common stock held by such reporting person, for a total consideration of $4.95 per share based upon the closing price of Endologix common stock on February 2, 2016. These shares were withheld by the issuer as payment of the exercise price and to satisfy tax withholding obligations, and calculated for the purposes of the deemed exercise of the options, contingent upon the closing of the Merger, utilizing the closing price of the issuers common stock on January 28, 2016. These restricted stock units became 100% vested in connection with the Merger. These stock options became 100% vested in connection with the Merger. /s/ Michael R. Kramer 2016-02-04